Why Immunome Stock Surged Today The oncology specialist's targeted therapies could improve thousands of lives.
Which stocks are gapping on Monday? In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Why Is IMNM Stock Rising Today? Immunome stock is on track to open at its highest levels in over 20 months, after the company reported positive topline results from its global Phase 3 RINGSIDE trial for a treatment targeting a type of connective tissue tumor.
These stocks are moving in today's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Curious about the stocks that are showing activity after the closing bell on Wednesday? Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
3 Small-Cap Stocks With Big Growth Potential Small-cap companies may give investors more targeted exposure to the U.S. economy; these companies are three leaders in the space.
Immunome Stock Sees RS Rating Jump To 91 Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.
IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024 IMNM stock results show that Immunome missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
